Analysis on Rationality and Safety of the Application of Nonsteroidal Anti-Inflammatory Drug on 205 Patients in Department of Medical Oncology

GAO Rongyin; LIU Feiye; XU Wei

doi:10.14009/j.issn.1672-2124.2020.08.027

您当前的位置：

首页 >

文章列表页 >

Analysis on Rationality and Safety of the Application of Nonsteroidal Anti-Inflammatory Drug on 205 Patients in Department of Medical Oncology

更新时间：2022-10-08

- Analysis on Rationality and Safety of the Application of Nonsteroidal Anti-Inflammatory Drug on 205 Patients in Department of Medical Oncology
- Vol. 20, Issue 8, Pages: 996-1000(2020)
- 作者机构：
  
  1. 常州市第一人民医院/苏州大学附属第三医院药事科
  2. 山东省千佛山医院药学部
  3. 山东大学药学院
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.08.027
  CLC： R969.3
- Published：2020，
扫描看全文
[1]高榕荫,刘斐烨,徐巍.205例肿瘤内科住院患者非甾体抗炎药的临床应用合理性和安全性分析[J].中国医院用药评价与分析,2020,20(08):996-1000.

GAO Rongyin, LIU Feiye, XU Wei. Analysis on Rationality and Safety of the Application of Nonsteroidal Anti-Inflammatory Drug on 205 Patients in Department of Medical Oncology. [J]. 20(8):996-1000(2020)
[1]高榕荫,刘斐烨,徐巍.205例肿瘤内科住院患者非甾体抗炎药的临床应用合理性和安全性分析[J].中国医院用药评价与分析,2020,20(08):996-1000. DOI： 10.14009/j.issn.1672-2124.2020.08.027.

GAO Rongyin, LIU Feiye, XU Wei. Analysis on Rationality and Safety of the Application of Nonsteroidal Anti-Inflammatory Drug on 205 Patients in Department of Medical Oncology. [J]. 20(8):996-1000(2020) DOI： 10.14009/j.issn.1672-2124.2020.08.027.

摘要

目的:了解肿瘤内科住院患者非甾体抗炎药的使用情况

为进一步规范合理使用非甾体抗炎药提供依据。方法:回顾性分析2019年山东省千佛山医院肿瘤内科住院患者使用非甾体抗炎药的相关数据

统计患者基本信息、胃肠道和心血管危险因素以及非甾体抗炎药的使用情况、不良反应发生情况。结果:共纳入205例患者。非甾体抗炎药临床使用的主要问题包括

（1）未按照胃肠道风险管理使用非甾体抗炎药（占35.61%

73/205）;（2）未按照心血管风险管理使用非甾体抗炎药（占40.49%

83/205）;（3）用法、用量不适宜（占4.39%

9/205）;（4）疗程不适宜（占7.80%

16/205）。结论:肿瘤内科非甾体抗炎药的使用存在较多不合理现象

主要问题是未重视患者的胃肠道和心血管危险因素分层管理

需加强监管和干预

提升合理用药水平。

Abstract

OBJECTIVE:To investigate the application of nonsteroidal anti-inflammatory drug（NSAID）.METHODS:To retrospectively analyze the data related to the application of NSAID on inpatients in department of medical oncology in Shandong Provincial Qianfoshan Hospital in 2019

to collect the basic information

gastrointestinal and cardiovascular risk factors

application of NSAID and incidences of adverse drug reactions of patients.RESULTS:A total of 205 patients were involved.Main problems in the clinical application of NSAID included:（1） NSAID were not used in accordance with gastrointestinal risk management（35.61%

73/205）;（2） NSAID were not used in accordance with cardiovascular risk management（40.49%

83/205）;（3） improper usage and dosage（4.39%

9/205）;（4） inappropriate course of treatment（7.80%

16/205）.CONCLUSIONS:There are some irrational application of NSAID in department of medical oncology

and the main problem is the lack of attention to the hierarchical management of gastrointestinal and cardiovascular risk factors in patients

and the supervision and intervention are needed to improve rational medication.

关键词

肿瘤内科非甾体抗炎药胃肠道风险心血管风险合理用药

Keywords

Medical oncologyNonsteroidal anti-inflammatory drugsGastrointestinal risk factorsCardiovascular risk factorsRational drug application

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application Rationality of Traditional Chinese Medicine Injections in Our Hospital from the Perspective of Adjuvant Drug Management

Key Points and Reflections of Rational Clinical Application of Anti-Tumor Traditional Chinese Medicine Injection

Application Rationality of Probiotics in Children with Inflammatory Bowel Disease in Two Children’s Hospitals of Beijing

Analysis on Rationality and Research on Drug Utilization of Lienal Polypeptide Injection in 296 Children

An Annual Effect Analysis on the First Batch of Pilot Project of National-Organized Centralized Drug Procurement and Application in A Certain Grade Ⅲ Level A General Hospital in Chongqing

Related Author

SUN Shijiang

CHENG Jie

CHEN Pinying

FAN Shunxin

SHI Jing

GAO Xu

MA Juanjuan

LI Lianying

Related Institution

Dept.of Pharmacy, Traditional Chinese Medicine Hospital of Hebei Luanping County

Dept.of Pharmacy, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei Industrial Technology Institute for Traditional Chinese Medicine Preparation

Dept.of Medical Oncology, Guang’anmen Hospital of China Academy of Chinese Medical Sciences

Dept.of Pharmacy, Guang’anmen Hospital of China Academy of Chinese Medical Sciences

Clinical Research Center,Beijing Children’s Hospital,Capital Medical University

⁰